Access cutting-edge als treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access als specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related als treatment provided free
The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Sponsor: AB Science
Check if you qualify for this als clinical trial in Birmingham, AL
If you're searching for als treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced als specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.